Počet záznamů: 1
A myeloperoxidase promoter polymorphism is independently associated with mortality in patients with impaired left ventricular function
- 1.0340135 - BFÚ 2010 RIV US eng J - Článek v odborném periodiku
Rudolph, V. - Rudolph, T.K. - Kubala, Lukáš - Clauberg, N. - Maas, R. - Pekarová, Michaela - Klinke, A. - Lau, D. - Szöcs, K. - Meinertz, T. - Böger, R.H. - Baldus, S.
A myeloperoxidase promoter polymorphism is independently associated with mortality in patients with impaired left ventricular function.
Free Radical Biology and Medicine. Roč. 47, č. 11 (2009), s. 1584-1590. ISSN 0891-5849. E-ISSN 1873-4596
Grant CEP: GA ČR(CZ) GA524/08/1753
Výzkumný záměr: CEZ:AV0Z50040507; CEZ:AV0Z50040702
Klíčová slova: myeloperoxidase * heart failure * free radicals
Kód oboru RIV: BO - Biofyzika
Impakt faktor: 6.081, rok: 2009
Circulating levels of myeloperoxidase (MPO), a heme enzyme released upon activation of polymorphonuclear neutrophils, predict adverse outcome in patients with impaired left ventricular (LV) function. There is no association of the MPO polymorphism with total MPO protein concentration or MPO activity in plasma.
Trvalý link: http://hdl.handle.net/11104/0183441
Počet záznamů: 1